Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Roberta Ceruti"'
Autor:
Alessia Casolaro, Josee Golay, Clara Albanese, Roberta Ceruti, Veronica Patton, Sabrina Cribioli, Alice Pezzoni, Marco Losa, Gemma Texido, Ursula Giussani, Francesco Marchesi, Nadia Amboldi, Barbara Valsasina, Silvia Bungaro, Gianni Cazzaniga, Alessandro Rambaldi, Martino Introna, Enrico Pesenti, Rachele Alzani
Publikováno v:
PLoS ONE, Vol 8, Iss 3, p e58424 (2013)
CD56 is expressed in 15-20% of acute myeloid leukaemias (AML) and is associated with extramedullary diffusion, multidrug resistance and poor prognosis. We describe the establishment and characterisation of a novel disseminated model of AML (AML-NS8),
Externí odkaz:
https://doaj.org/article/9ff701b67ac14375b7e6e3ca8f819c84
Autor:
Jürgen Moll, Daniele Fancelli, Enrico Pesenti, Dario Ballinari, Aurelio Marsiglio, Veronica Patton, Cristina Alli, Chiara Soncini, Claudio Arrigoni, Paola Zugnoni, Paola Storici, Luisa Rusconi, Paola Vianello, Maurizio Rocchetti, Gemma Texido, Anna Degrassi, Valter Croci, Laura Gianellini, Paolo Cappella, Maria Laura Giorgini, Roberta Ceruti, Patrizia Carpinelli
Supplementary Fig. S1 from PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ad37abd8e1e506016be814b1b51c632
https://doi.org/10.1158/1535-7163.22483142.v1
https://doi.org/10.1158/1535-7163.22483142.v1
Autor:
Howard A. Burris, Jurgen Moll, Bernard Laffranchi, Silvia Comis, Roberta Ceruti, Maurizio Rocchetti, Mariangela Mariani, F. Anthony Greco, David R. Spigel, Jonathan Cheng, Margaret von Mehren, Charu Aggarwal, Suzanne F. Jones, Roger B. Cohen
Purpose: This study was conducted to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of the i.v. pan-aurora kinase inhibitor PHA-739358, danusertib, in patients with advanced solid tumors.Experimental Design: In part 1, patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f464a8357ae84ce0b861e75ce7c7794
https://doi.org/10.1158/1078-0432.c.6517320
https://doi.org/10.1158/1078-0432.c.6517320
Autor:
Jürgen Moll, Daniele Fancelli, Enrico Pesenti, Dario Ballinari, Aurelio Marsiglio, Veronica Patton, Cristina Alli, Chiara Soncini, Claudio Arrigoni, Paola Zugnoni, Paola Storici, Luisa Rusconi, Paola Vianello, Maurizio Rocchetti, Gemma Texido, Anna Degrassi, Valter Croci, Laura Gianellini, Paolo Cappella, Maria Laura Giorgini, Roberta Ceruti, Patrizia Carpinelli
Supplementary Table S1 from PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c070b33c5aefdf25ed1f037d109f678
https://doi.org/10.1158/1535-7163.22483139.v1
https://doi.org/10.1158/1535-7163.22483139.v1
Autor:
Howard A. Burris, Jurgen Moll, Bernard Laffranchi, Silvia Comis, Roberta Ceruti, Maurizio Rocchetti, Mariangela Mariani, F. Anthony Greco, David R. Spigel, Jonathan Cheng, Margaret von Mehren, Charu Aggarwal, Suzanne F. Jones, Roger B. Cohen
Supplementary Data from A Phase I Dose-Escalation Study of Danusertib (PHA-739358) Administered as a 24-Hour Infusion with and without Granulocyte Colony-Stimulating Factor in a 14-Day Cycle in Patients with Advanced Solid Tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34e396a140f5dd4ac23e5e39cd5e57d6
https://doi.org/10.1158/1078-0432.22439934
https://doi.org/10.1158/1078-0432.22439934
Autor:
Jürgen Moll, Daniele Fancelli, Enrico Pesenti, Dario Ballinari, Aurelio Marsiglio, Veronica Patton, Cristina Alli, Chiara Soncini, Claudio Arrigoni, Paola Zugnoni, Paola Storici, Luisa Rusconi, Paola Vianello, Maurizio Rocchetti, Gemma Texido, Anna Degrassi, Valter Croci, Laura Gianellini, Paolo Cappella, Maria Laura Giorgini, Roberta Ceruti, Patrizia Carpinelli
PHA-739358 is a small-molecule 3-aminopyrazole derivative with strong activity against Aurora kinases and cross-reactivities with some receptor tyrosine kinases relevant for cancer. PHA-739358 inhibits all Aurora kinase family members and shows a dom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebb0bde1377ecffa21e6fcbd2a5240d3
https://doi.org/10.1158/1535-7163.c.6531083.v1
https://doi.org/10.1158/1535-7163.c.6531083.v1
Autor:
Roberta Ceruti, Arturo Galvani, Gemma Texido Romero, Federico Lussana, Elena Ardini, Antonella Isacchi, Paola Gnocchi, Daniele Casero, Gianmaria Borleri, Nilla Avanzi, Wilma Pastori, Alessandro Rambaldi, Marina Ciomei, Andrea Lombardi Borgia, Laura Gianellini
Publikováno v:
Cancer Research. 79:1324-1324
NMS-P088 is a potent and selective inhibitor of FLT3 and KIT kinases, including variants with both primary as well as secondary resistance mutations, in particular retaining potent activity against residue 691 gatekeeper mutation which still represen
Autor:
Monica Ganzinelli, Maria Antonietta Sabatino, Massimo Broggini, Cristina Geroni, Roberta Ceruti
Publikováno v:
Scopus-Elsevier
Brostallicin is a DNA minor groove binder that shows enhanced antitumor activity in cells with high glutathione S-transferase (GST)/glutathione content. Prostate cancer cells present, almost invariably, methylation of the GSTP1 gene promoter and, as
Autor:
Chiara Soncini, Enrico Pesenti, Paolo Cappella, Daniele Fancelli, Valter Croci, Paola Storici, Laura Gianellini, Patrizia Carpinelli, Francesco Sola, Paola Zugnoni, Dario Ballinari, Rodrigo Bravo, Mario Varasi, Jurgen Moll, Luisa Rusconi, Roberta Ceruti, Maria Laura Giorgini, Paola Vianello
Publikováno v:
Clinical Cancer Research. 12:4080-4089
Purpose: Aurora kinases play critical roles during mitosis in chromosome segregation and cell division. The aim of this study was to determine the preclinical profile of a novel, highly selective Aurora kinase inhibitor, PHA-680632, as a candidate fo
Autor:
Paolo Vezzoni, Giorgio Parmiani, Sabina Soldati, Monica Rodolfo, Marco Asioli, Eugenio Scanziani, Enrica Mira Catò, Roberta Ceruti, Maria Grazia Sacco
Publikováno v:
Cancer Gene Therapy. 8:491-496
The effect of local and systemic delivery of the angiostatin gene on human melanoma growth was studied in nude mice. Liposome-coated plasmids carrying the cDNA coding for murine and human angiostatin (CMVang and BSHang) were injected weekly, locally